Doctors in the US spent hours removing stem cells from the bone marrow of 12-year-old Kendric Cromer. These cells will be sent to a lab in New Jersey where researchers will infuse a healthy haemoglobin gene in them. Bluebird Bio, the company behind the pioneering treatment, says it can treat only 85 to 105 patients per year and that the therapy costs $3.1 million (Rs 26 crore)
Discover more from The Doon Mozaic
Subscribe to get the latest posts to your email.
